內臟疼痛治療市場：依藥物類型、適應症、通路和地區分類。

Visceral Pain Treatment Market, By Drug Type By Indications and By Distribution Channels By Region

出版日期: 2026年04月27日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，內臟疼痛治療市場規模將達到 170.4 億美元，到 2033 年將達到 254.5 億美元。預計從 2026 年到 2033 年，該市場將以 5.9% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	170.4億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	5.90%	2033年市場規模預測：	254.5億美元

內臟疼痛是由骨盆、胸部或腹部內臟器官（內臟）中的傷害感受器活化引起的。內臟結構對牽拉、發炎和缺血高度敏感，但對其他一些常引起疼痛的刺激（例如灼熱感或切割感）的敏感度較低。內臟疼痛的症狀包括嘔吐、噁心、生命徵象變化和情緒波動。Pregabalin和Gabapentin是用來治療內臟疼痛的藥物。內臟疼痛是指子宮、胃、直腸和膀胱等內臟器官發炎所引起的內部疼痛。這種發炎可由多種因素引起，包括感染疾病、創傷以及器官的外部或內部損傷。內臟疼痛的強度各不相同，從劇烈疼痛到持續性疼痛，或感覺來自身體深處的疼痛。

市場動態

內臟疼痛治療方法的不斷增加預計將推動全球內臟疼痛治療市場的成長。例如，2022年12月31日發表在《美國生理學雜誌》上的報導指出，目前有效的慢性疼痛治療方法寥寥無幾。鴉片類藥物危機凸顯了闡明慢性疼痛機制並開發無鴉片類藥物不可接受副作用的新療法的迫切需求。急性疼痛是一種對生存至關重要的生理過程，因為它使我們能夠識別並避免傷害。慢性疼痛可能與疾病（例如癌症、發炎性疾病、功能性胃腸疾病、糖尿病）、創傷（例如神經創傷）和治療（例如化療）有關，甚至在患者康復後也可能持續存在。與其他器官相比，內臟器官中的疼痛感受器分佈密度和均勻性較低，這使得疼痛的識別和治療更加困難。

本研究的主要特點：

這項研究揭示了各個細分市場的潛在成長機會，並為該市場說明了一個有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球內臟疼痛治療市場主要參與者的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本研究涵蓋的主要公司包括 Addex Therapeutics Ltd.、Astra Zeneca、Astellas製藥、艾爾建、Chromocell Corporation、武田藥品工業株式會社、GIcare Pharma Inc.、艾伯維、Grunenthal GmbH、強生、Neurim Pharmaceuticals Ltd. 和 Medestea Research & Production SpA。
本報告提供的見解將有助於各公司的行銷負責人和經營團隊就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份「全球內臟疼痛治療市場報告」旨在為該行業的各種相關人員提供服務，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球內臟疼痛治療市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

Addex Therapeutics Ltd.
AstraZeneca
Astellas Pharma Inc.
Allergan
Chromocell Corporation
Takeda
GIcare Pharma Inc.
Abbvie
Grunenthal GmbH
Johnson & Johnson
Neurim Pharmaceuticals Ltd
Medestea Research & Production SpA

第9章

調查方法
關於本公司

簡介目錄

Product Code: CMI4095

Visceral Pain Treatment Market is estimated to be valued at USD 17.04 Bn in 2026 and is expected to reach USD 25.45 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 17.04 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.90%	2033 Value Projection:	USD 25.45 Bn

Visceral pain results from the activation of nociceptors in the viscera (organs) of the pelvis, chest, or abdomen. Visceral structures are very sensitive to stretching (stretching), inflammation, and ischemia, but moderately sensitive to other stimuli that often cause pain such as burning or cutting. Symptoms of visceral pain include vomiting, nausea, changes in vital signs, and emotional manifestations. Pregabalin or gabapentin are some drugs used to treat visceral pain. Visceral pain is defined as internal pain caused by inflammation of internal organs such as the uterus, stomach, rectum, and bladder. This inflammation is caused by several factors such as infection, trauma, and external or internal injuries to internal organs. Visceral pain varies in intensity from sharp, constant, or occasionally deep, like urgent at the body.

Market Dynamics

Increasing number of treatments of visceral pain are expected to drive the global visceral pain treatment market growth. For instance, on December 31, 2022, American Journal of Physiology published an article stating there are few effective treatments for chronic pain. The opioid crisis emphasizes the urgent need to clarify the mechanisms of chronic pain and to develop new forms of treatment that do not have the unacceptable side effects of opioids. Acute pain is a physiological process that is necessary for survival because it allows the awareness and avoidance of injury. Chronic pain can accompany disease (e.g., cancer, inflammatory diseases, functional GI disorders, and diabetes), injury (e.g., neurotrauma) and therapy (e.g., chemotherapy), and can persist after patient the patient is healed. In the visceral organs, pain receptors are not as closely packed and not as evenly spread out as in other organs, which makes the pain's origin much harder to pinpoint and treat.

Key features of the study:

It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global visceral pain treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Addex Therapeutics Ltd., AstraZeneca, Astellas Pharma Inc., Allergan, Chromocell Corporation, Takeda, GIcare Pharma Inc., Abbvie, Grunenthal GmbH, Johnson & Johnson, Neurim Pharmaceuticals Ltd, and Medestea Research & Production S.p.A.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global visceral pain treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global visceral pain treatment market

Detailed Segmentation:

Global Visceral Pain Treatment Market, By Drug Type (Revenue, USD Bn, 2021 - 2033)
Pain modifiers
- Tricyclic Anticonvulsant
- Tricyclic Antidepressants
Analgesics
- Narcotics
- NSAID
Others
Global Visceral Pain Treatment Market, By Indication (Revenue, USD Bn, 2021 - 2033)
Chronic Prostatitis
Interstitial Cystitis
Crohn's Disease
Irritable Bowel Syndrome
Global Visceral Pain Treatment Market, By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
Hospital Pharmacy
Retail Pharmacy
Online Channels
Global Visceral Pain Treatment Market, By Region (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- North Africa
- Central Africa
- South Africa
Company Profiles
Addex Therapeutics Ltd.
AstraZeneca
Astellas Pharma Inc.
Allergan
Chromocell Corporation
Takeda
GIcare Pharma Inc.
Abbvie
Grunenthal GmbH
Johnson & Johnson
Neurim Pharmaceuticals Ltd
Medestea Research & Production S.p.A

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Indication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Visceral Pain Treatment Market, By Drug Type, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Pain modifiers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  - Tricyclic Anticonvulsant
  - Tricyclic Antidepressants
Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  - Narcotics
  - NSAID
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

5. Global Visceral Pain Treatment Market, By Indication , 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Chronic Prostatitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Interstitial Cystitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Crohn's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Irritable Bowel Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

6. Global Visceral Pain Treatment Market, By Distribution Channel , 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Online Channels
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

7. Global Visceral Pain Treatment Market, By Region, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021-2033, (US$ Billion)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Addex Therapeutics Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Astellas Pharma Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Allergan
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Chromocell Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Takeda
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
GIcare Pharma Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Abbvie
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Grunenthal GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Neurim Pharmaceuticals Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Medestea Research & Production S.p.A
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies